As Oxford PharmaGenesis™ enters its second
decade, we reflect on the impact that changes in the pharmaceutical industry have on medical communications, and how we set out to meet these emerging challenges. Foremost among these is the
ever-increasing time to market.

From the time of the patent application in preclinical testing, an important clock starts ticking. Longer timelines for clinical development and regulatory approval are increasingly leading to delays, which can reduce revenues available for future pharmaceutical development. Oxford PharmaGenesis™ enables the timely delivery of strategic publications and other communications to ensure that clinical trial results are published and disseminated to support launch.

Other industry-wide challenges include: